ProPharma Group, a portfolio company of Linden Capital Partners, announces the acquisition of Xendo Holding B.V., which also includes Sofus Regulatory Affairs AB, based in Sweden.

“We are excited to support the entire ProPharma Group organization as they continue to build out capabilities and expand their global presence to better serve their customers,” said Michael Farah, Chairman of ProPharma Group and Partner at Linden Capital Partners.

This acquisition expands ProPharma Group’s geographic coverage for compliance consulting services to include Europe and adds additional high-value regulatory affairs and pharmacovigilance services.

“We are thrilled about our future as part of ProPharma Group. The combination expands our global reach and service offering to our clients”, said André van de Sande, Xendo’s CEO.